| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/21/2014 | US8633355 Modification of plant flavonoid metabolism |
| 01/21/2014 | US8633302 Variable tangential flow filtration |
| 01/21/2014 | US8633297 Protein scaffolds |
| 01/21/2014 | US8633163 Template-fixed peptidomimetics |
| 01/21/2014 | US8633159 Apparatus and method for transdermal delivery of parathyroid hormone agents |
| 01/21/2014 | US8633157 Glycopegylated erythropoietin |
| 01/21/2014 | US8633153 Transthyretin variants |
| 01/21/2014 | US8633151 Ghrelin analogs |
| 01/21/2014 | US8633030 Polypeptides having carboxypeptidase activity and polynucleotides encoding same |
| 01/21/2014 | US8633024 PDX1 expressing endoderm |
| 01/21/2014 | US8633018 Fusion protein containing a single-stranded DNA binding protein and methods for expression and purification of the same |
| 01/21/2014 | US8632985 Binding molecules for the treatment of myeloid cell malignancies |
| 01/21/2014 | US8632972 Methods and compositions for identifying RNA-binding proteins |
| 01/21/2014 | US8632801 Stable therapeutic formulations |
| 01/21/2014 | US8632784 Nucleic acids and proteins from Streptococcus pneumoniae |
| 01/21/2014 | US8632783 Compositions for immunising against Staphylococcus aureus |
| 01/21/2014 | US8632782 Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region |
| 01/21/2014 | US8632781 Immunogenic compounds comprising peptides of IL1β |
| 01/21/2014 | US8632780 Human complement C3 derivates with cobra venom factor-like function |
| 01/21/2014 | US8632779 S. aureus polypeptides and antibodies |
| 01/21/2014 | US8632565 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 01/21/2014 | CA2698396C Interferon alpha2a modified by polyethylene glycol, the preparation and use thereof |
| 01/21/2014 | CA2673373C Rsv f-protein and its use |
| 01/21/2014 | CA2665748C Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
| 01/21/2014 | CA2638757C Chimeric adenoviral vectors |
| 01/21/2014 | CA2616258C Non-human animal model for cardiovascular disease characterized by a disrupted fibulin-4 gene |
| 01/21/2014 | CA2595115C Fusion proteins for treating, preventing or ameliorating pain |
| 01/21/2014 | CA2559144C Estrogen receptor alpha splice variant er-.alpha.36 |
| 01/21/2014 | CA2427257C Expression vectors able to elicit improved immune response and methods of using same |
| 01/21/2014 | CA2414374C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/21/2014 | CA2388477C Recombinant gelatins with uniform molecular weight |
| 01/21/2014 | CA2378437C Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 01/21/2014 | CA2359317C Method of treating restenosis by antisense targeting of c-myc |
| 01/21/2014 | CA2341763C Antigenic peptides of aglyco 10b and antibodies thereto |
| 01/21/2014 | CA2236868C Conditionally replicating viral vectors and their use |
| 01/16/2014 | WO2014012087A2 Doped chiral polymer metamaterials |
| 01/16/2014 | WO2014012085A2 Bispecific asymmetric heterodimers comprising anti-cd3 constructs |
| 01/16/2014 | WO2014012082A2 Multivalent heteromultimer scaffold design an constructs |
| 01/16/2014 | WO2014011996A1 Methods of assessing the suitability of transduced t cells for administration |
| 01/16/2014 | WO2014011908A1 Apolipoprotein mixtures |
| 01/16/2014 | WO2014011829A1 Protein complex system for increased immunogenicity and functionality, and methods making and use |
| 01/16/2014 | WO2014011819A2 Factor viii complex with xten and von willebrand factor protein, and uses thereof |
| 01/16/2014 | WO2014011813A1 Compositions containing hc-ha/ptx3 complexes and methods of use thereof |
| 01/16/2014 | WO2014011732A1 Compositions and methods for modulation of il-20 family cytokine activity |
| 01/16/2014 | WO2014011052A1 Hypo-allergenic cross-linked proteins for use in the prevention of an allergy against milk-proteins and for use in the induction of oral tolerance |
| 01/16/2014 | WO2014011003A1 Crystallization method for trx-txnip complex denatured protein, and three-dimensional structure thereof |
| 01/16/2014 | WO2014010985A1 Peptide for highly efficient introduction and maintenance of intracellular protein |
| 01/16/2014 | WO2014010635A1 Fluorescent probe for cell observation and method using same |
| 01/16/2014 | WO2014010232A1 Ly6k epitope peptides for th1 cells and vaccines containing the same |
| 01/16/2014 | WO2014010231A1 Kif20a epitope peptides for th1 cells and vaccines containing the same |
| 01/16/2014 | WO2014010229A1 Cdca1 epitope peptides for th1 cells and vaccines containing the same |
| 01/16/2014 | WO2014010055A1 Epithelial ovarian cancer differentiation marker |
| 01/16/2014 | WO2014009808A2 Lipidated peptides as anti-obesity agents |
| 01/16/2014 | WO2014009763A1 Novel lantipeptide |
| 01/16/2014 | WO2014009733A2 Therapeutic targets for alzheimer's disease |
| 01/16/2014 | WO2014009590A1 Apoaequorin mutants and methods for the use thereof |
| 01/16/2014 | WO2014009567A1 Compositions and methods for duchenne muscular dystrophy gene therapy |
| 01/16/2014 | WO2014009276A1 Recombinantly produced neutral protease originating from paenibacillus polymyxa |
| 01/16/2014 | WO2014009259A1 Cell penetrating peptides to target eif4e |
| 01/16/2014 | WO2013180537A3 Skin-permeating peptide |
| 01/16/2014 | WO2013177584A3 FVIIa VARIANTS EXHIBITING ALTERED INTERACTION WITH ENDOTHELIAL PROTEIN C RECEPTOR (EPCR) FOR MODULATING HEMOSTASIS |
| 01/16/2014 | WO2013162772A3 Perforin 2 defense against invasive and multidrug resistant pathogens |
| 01/16/2014 | WO2013071113A3 Method of fracturing using mannanohydrolase enzyme breaker |
| 01/16/2014 | WO2009046535A8 Methods for assaying mc1r variants and mitochondrial markers in skin samples |
| 01/16/2014 | US20140020130 csRRM2 GENE AND ITS USE FOR IMPROVING TRAITS IN INDUSTRIAL CROPS |
| 01/16/2014 | US20140018520 Antifungal plant proteins and methods of their use |
| 01/16/2014 | US20140018519 Stabilized Fibronectin Domain Compositions, Methods and Uses |
| 01/16/2014 | US20140018297 Compounds suitable for treatment of haemophilia |
| 01/16/2014 | US20140018290 Leptin derivatives |
| 01/16/2014 | US20140018288 X-DING-CD4 Peptide |
| 01/16/2014 | US20140018286 Amylin analogues and pharmaceutical compositions thereof |
| 01/16/2014 | US20140018247 Amis/urei urea-channel superfamily crystal structures |
| 01/16/2014 | US20140017790 Control agent for controlling undifferentiated state and use thereof |
| 01/16/2014 | US20140017774 Pca3, pca3 genes, and methods of use |
| 01/16/2014 | US20140017727 Cna-B DOMAIN ANTIGENS IN VACCINES AGAINST GRAM POSITIVE BACTERIA |
| 01/16/2014 | US20140017725 Methods of Making Nanotechnological and Macromolecular Biomimetic Structures |
| 01/16/2014 | US20140017715 Alpha-amylase Mutants |
| 01/16/2014 | US20140017681 Treatment of disease |
| 01/16/2014 | US20140017480 Doped chiral polymer metamaterials |
| 01/16/2014 | US20140017295 Hemostatic material |
| 01/16/2014 | US20140017278 Adenovirus serotype 26 and serotype 35 filovirus vaccines |
| 01/16/2014 | US20140017273 Albumin-Fused Anti-Angiogenesis Peptides |
| 01/16/2014 | US20140017272 Transgenic algae for delivering antigens to an animal |
| 01/16/2014 | US20140017270 Small streptococcus pyogenes antigens and their use |
| 01/16/2014 | US20140017269 Protein complex system for increased immunogenicity and functionality, and methods making and use |
| 01/16/2014 | US20140017268 Composition and Methods for Detecting or Preventing Lawsonia intracellularis Infections |
| 01/16/2014 | US20140017266 Anti-podoplanin antibodies and methods of use |
| 01/16/2014 | US20140017259 Immunotherapy against erbb-3 receptor |
| 01/16/2014 | US20140017254 Identification of Tumor-Associated Antigens for Diagnosis and Therapy |
| 01/16/2014 | US20140017251 Botulinum neurotoxin a receptor and the use thereof |
| 01/16/2014 | US20140017201 Viral vectors for the treatment of retinal dystrophy |
| 01/16/2014 | CA2878081A1 Methods for synthesizing amatoxin building block and amatoxins |
| 01/16/2014 | CA2877594A1 Lipidated peptides as anti-obesity agents |
| 01/16/2014 | CA2876730A1 Enhancing activity of car t cells by co-introducing a bispecific antibody |
| 01/15/2014 | EP2684894A2 Identification of tumor-associated markers for diagnosis and therapy |
| 01/15/2014 | EP2684893A2 Identification of tumor-associated markers for diagnosis and therapy |
| 01/15/2014 | EP2684892A1 Compositions and methods for duchenne muscular dystrophy gene therapy |
| 01/15/2014 | EP2684891A2 Recombinant silk protein derived from sea anemones, method for manufacturing same, and composition for manufacturing silk fibers including same |
| 01/15/2014 | EP2684890A1 Methods of intracellular conversion of single-chain proteins into their di-chain form |
| 01/15/2014 | EP2684889A2 Multivariable antigens complexed with targeting humanized monoclonal antibody |